PTAIY yields 6.34% · JNJ yields 2.13%● Live data
📍 PTAIY pulled ahead of the other in Year 1
Combined, PTAIY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PTAIY + JNJ for your $10,000?
PT Astra International Tbk, together with its subsidiaries, operates in the automotive, financial services, heavy equipment, mining, construction, energy, agri, infrastructure and logistics, information technology, and property businesses in Indonesia. It offers cars, trucks, and motorcycles of various brands; manufactures and sells automotive components to the original equipment for manufacturers and replacement markets, as well as provides consultation services to its customers; financing for cars, motorcycles, and heavy equipment; life, vehicle, and health insurance, as well as other insurance for commercial business; and various banking products and services. The company also distributes heavy equipment for the mining, plantation, construction, forestry, transportation, and material handling industries; provides coal mining contracting services; operates coal mines; and produces crude palm oil. In addition, it is involved in the operation of toll roads; rental of vehicles; sale of used cars; and provision of logistics and warehousing services, as well as freight forwarding service through ground, sea, and air transportation. Further, the company offers various information technology business solutions based on document, information, and communication technology; and engages in the property development and management activities. Additionally, it is involved in the foundation; formwork and bekisting; pump services; and mechanical, electrical, and plumbing works. The company was incorporated in 1957 and is headquartered in Jakarta, Indonesia. PT Astra International Tbk is a subsidiary of Jardine Cycle & Carriage Limited.
Full PTAIY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.